Worth Venture Partners, LLC Organogenesis Holdings Inc. Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$2.86 - $4.61 $348,513 - $561,765
-121,858 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$2.92 - $5.31 $134,734 - $245,014
-46,142 Reduced 27.47%
121,858 $393,000
Q4 2019

Feb 14, 2020
BUY
$4.7 - $8.11 $789,600 - $1.36 Million
168,000 New
168,000 $808,000

Others Institutions Holding ORGO

# of Institutions
117
Shares Held
63.2M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $516M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email